Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06590285 · ClinicalTrials.gov registry record · NA

Diagnostic Refinement and Educational Approaches in Managing Bone Marrow Transplantation

A NA study of Bone Marrow Transplant Complications and GvHD, sponsored by Scripps Health.

Recruiting
Registry status
NA
Development phase
60
Enrollment target
1
Study location

NCT06590285: Recruiting NA study of Bone Marrow Transplant Complications and GvHD, sponsored by Scripps Health.

NCT06590285 is a NA study of Bone Marrow Transplant Complications and GvHD that is actively recruiting participants, run by Scripps Health. The registered enrollment target is 60 participants, below the 317-participant average among 6 other Bone Marrow Transplant Complications trials with a reported enrollment target (81% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06590285, a NA study of Bone Marrow Transplant Complications and GvHD, is actively recruiting participants, sponsored by Scripps Health.

RECRUITING
Registry status
NA
Development phase
60 participants
Enrollment target
1
Study location

Study Summary

This randomized, phase I/II, open-label study will investigate the efficacy and safety of an educational sleep intervention vs standard of care in adults undergoing alloHSCT. The randomization target in this pilot phase is 60 patients.

Primary Outcome

A wearable device will continuously measure objective sleep quality. The outcome will be reported as the average sleep duration (in minutes per day) over the study period. Data will be aggregated for the entire duration of the study.

Interventions

  • BEHAVIORAL App-based Educational Intervention

Study Locations (1)

California

  • Scripps Health - San Diego

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2026-03-01
Est. Completion 2033-10-01
Phase NA
Scripps Health

30 total trials

What NCT06590285 shows while recruiting

NCT06590285 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 317-participant average among 6 other Bone Marrow Transplant Complications trials with a reported enrollment target (81% lower).

The record links to 2 conditions, with Bone Marrow Transplant Complications appearing as the primary indexed condition, and to 1 intervention - of which App-based Educational Intervention is the first listed.

NCT06590285 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT06590285 about?

NCT06590285 is a clinical study titled "Diagnostic Refinement and Educational Approaches in Managing Bone Marrow Transplantation". This randomized, phase I/II, open-label study will investigate the efficacy and safety of an educational sleep intervention vs standard of care in adults undergoing alloHSCT. The randomization target in this pilot phase is 60 patients.

What is the current status of trial NCT06590285?

This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2026-03-01. Estimated completion is 2033-10-01.

What conditions does trial NCT06590285 study?

This clinical trial studies the following conditions: Bone Marrow Transplant Complications, GvHD.

What interventions are being tested in trial NCT06590285?

The interventions under investigation include: App-based Educational Intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT06590285?

This trial is sponsored by Scripps Health, which has 30 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06590285 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Bone Marrow Transplant Complications

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00576069 · 60 participants

    Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma

  • NCT01297400 · 60 participants · Phase 2

    Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns

  • NCT01734122 · 60 participants

    Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor

  • NCT01804634 · 60 participants · Phase 2

    Reduced Intensity Haploidentical BMT for High Risk Solid Tumors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06590285, the US trial registry maintained by the National Library of Medicine. NCT06590285 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.